Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maity AP"'
Autor:
Maity AP; Lankenau Medical Center, Wynnewood, PA., Gangireddy M; Lankenau Medical Center, Wynnewood, PA., Degen KC; Lankenau Medical Center, Wynnewood, PA., Al-Saleem FH; Lankenau Institute for Medical Research, Wynnewood, PA., Bramson J; Atlantic Hematology and Oncology, Neptune, NJ., Ciocca V; Lankenau Medical Center, Wynnewood, PA., Dessain SK; Lankenau Medical Center, Wynnewood, PA.; Lankenau Institute for Medical Research, Wynnewood, PA., Evans TL; Lankenau Institute for Medical Research, Wynnewood, PA.; Paoli Hematology Oncology Association, Paoli, PA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 620-625. Date of Electronic Publication: 2023 Jun 15.
Autor:
Aggarwal C; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Maity AP; Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA, USA., Bauml JM; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Long Q; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Aleman T; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Ciunci C; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., D'Avella C; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Volpe M; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Anderson E; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Jones LM; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Sun L; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Singh AP; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Marmarelis ME; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Cohen RB; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Langer CJ; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Amaravadi R; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Jul 05; Vol. 28 (7), pp. 644-e564.
Autor:
Maity A; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Mick R; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA., Rengan R; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA., Mitchell TC; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Amaravadi RK; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Schuchter LM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Pryma DA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Patsch DM; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Maity AP; Department of Medicine, Lankenau Medical Center, Wynnewood, PA, USA., Minn AJ; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, University of Pennsylvania, Philadelphia, PA, USA., Vonderheide RH; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lukens JN; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2021 Jan 31; Vol. 10 (1), pp. 1863631. Date of Electronic Publication: 2021 Jan 31.